| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |